Here’s the thing
if C Harris is the next US President she is going to slash the Pharmas drugs which are to expensive
Gene therapy drugs fit in that category..
Sareptas $3.2 million
GT drugs around $200,000 / $300,000
Look at Atl1102
$100,000 per annum
Guess who’s going to come out a winner
Sarepta is not making a profit… how long can they hold out ?
We wait .
per-chart, page-1178
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
